Great West Life Assurance CO Iovance Biotherapeutics, Inc. Transaction History
Great West Life Assurance CO
- $69.9 Billion
- Q3 2025
A detailed history of Great West Life Assurance CO transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 34,025 shares of IOVA stock, worth $84,041. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,025
Previous 30,404
11.91%
Holding current value
$84,041
Previous $52,000
46.15%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding IOVA
# of Institutions
291Shares Held
222MCall Options Held
2.41MPut Options Held
1.7M-
Mhr Fund Management LLC New York, NY29MShares$71.5 Million10.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA27.2MShares$67.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$52.4 Million0.0% of portfolio
-
State Street Corp Boston, MA13.3MShares$32.9 Million0.0% of portfolio
-
Invenomic Capital Management LP Boston, MA10.5MShares$26 Million1.15% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $390M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...